Literature DB >> 3621111

Polyamine biosynthetic activity in normal and neoplastic human colorectal tissues.

C W Porter, L Herrera-Ornelas, P Pera, N F Petrelli, A Mittelman.   

Abstract

Polyamine biosynthetic activity was assessed in various colorectal tissue samples consisting of noninvolved mucosa, benign adenomatous polyps and adenocarcinomas taken at surgery from a total of 40 patients. Ornithine decarboxylase (ODC) displayed a gradient of enzyme activity (i.e., adenocarcinoma greater than polyps greater than mucosa) which seemed to correlate positively with the neoplastic status of the tissue. In 10 of the patients, samples were obtained for all three tissue types. Five of these exhibited a clear repetition of the trends in enzyme activity seen with the mixed patient tissue sampling whereas the remainder differed by having the highest ODC activity in the polyps. In nine of the ten cases, ODC activity was substantially lower in the mucosa than in either of the neoplastic lesions. Trends in enzyme activity were the same for tissues obtained from either the colon or rectum. The ODC activity in adenocarcinomas could not be correlated with histologic differentiation, stage or site of the disease, however, in samples from female patients (all postmenopausal) the activity was elevated over normal mucosa to a greater extent (ten-fold) than in male patients (seven-fold). S-adenosylmethionine decarboxylase activity was assessed in 27 of the 40 patients and found to follow the same distribution as ODC; however, the mean value differences +/- SEM between tissues were less distinct. In general, tissue polyamine pool analysis of these same specimens reflected the levels of ornithine and S-adenosylmethionine decarboxylase activities. Overall, the data reveal an increase in polyamine biosynthetic activity in colorectal neoplasms, relative to surrounding mucosa, which may correlate with (1) progression of the neoplastic process, (2) the proportion of proliferating cells, (3) the rate of cell proliferation, or (4) a combination of two or all of these possibilities.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3621111     DOI: 10.1002/1097-0142(19870915)60:6<1275::aid-cncr2820600619>3.0.co;2-i

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  18 in total

1.  Increased colonic ornithine decarboxylase activity in inflammatory bowel disease in children.

Authors:  R B Pillai; V Tolia; R Rabah; P M Simpson; R Vijesurier; C H Lin
Journal:  Dig Dis Sci       Date:  1999-08       Impact factor: 3.199

2.  Pharmacological characteristics of the specific transporter for the endogenous cell growth inhibitor agmatine in six tumor cell lines.

Authors:  A Heinen; M Brüss; H Bönisch; M Göthert; G J Molderings
Journal:  Int J Colorectal Dis       Date:  2003-02-20       Impact factor: 2.571

Review 3.  A review of gene-drug interactions for nonsteroidal anti-inflammatory drug use in preventing colorectal neoplasia.

Authors:  J T Cross; E M Poole; C M Ulrich
Journal:  Pharmacogenomics J       Date:  2008-01-15       Impact factor: 3.550

4.  Multiple promoter elements govern expression of the human ornithine decarboxylase gene in colon carcinoma cells.

Authors:  J A Moshier; D L Osborne; M Skunca; J Dosescu; J D Gilbert; M C Fitzgerald; G Polidori; R L Wagner; S J Friezner Degen; G D Luk
Journal:  Nucleic Acids Res       Date:  1992-05-25       Impact factor: 16.971

5.  Role of ornithine decarboxylase in regulation of estrogen receptor alpha expression and growth in human breast cancer cells.

Authors:  Qingsong Zhu; Lihua Jin; Robert A Casero; Nancy E Davidson; Yi Huang
Journal:  Breast Cancer Res Treat       Date:  2012-09-14       Impact factor: 4.872

6.  Combination effects of platinum drugs and N1, N11 diethylnorspermine on spermidine/spermine N1-acetyltransferase, polyamines and growth inhibition in A2780 human ovarian carcinoma cells and their oxaliplatin and cisplatin-resistant variants.

Authors:  Ramakumar Tummala; Paula Diegelman; Suzanne Hector; Debora L Kramer; Kimberly Clark; Patricia Zagst; Gerald Fetterly; Carl W Porter; Lakshmi Pendyala
Journal:  Cancer Chemother Pharmacol       Date:  2010-05-05       Impact factor: 3.333

Review 7.  Polyamines in gastrointestinal cancer.

Authors:  R Saydjari; C M Townsend; S C Barranco; J C Thompson
Journal:  Dig Dis Sci       Date:  1989-10       Impact factor: 3.199

Review 8.  Applications of inulin and oligofructose in health and nutrition.

Authors:  Narinder Kaur; Anil K Gupta
Journal:  J Biosci       Date:  2002-12       Impact factor: 1.826

9.  A novel polyamine analog inhibits growth and induces apoptosis in human breast cancer cells.

Authors:  Yi Huang; Erin R Hager; Dawn L Phillips; Valerie R Dunn; Amy Hacker; Benjamin Frydman; John A Kink; Aldonia L Valasinas; Venodhar K Reddy; Laurence J Marton; Robert A Casero; Nancy E Davidson
Journal:  Clin Cancer Res       Date:  2003-07       Impact factor: 12.531

10.  Ornithine decarboxylase (ODC) levels in children with reflux esophagitis.

Authors:  Y Elitsur; W E Triest; C H Lin
Journal:  Dig Dis Sci       Date:  1994-04       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.